Cha SS - Search Results

1

HER-2/neu expression: a major prognostic factor in endometrial cancer.

Hetzel DJ, Wilson TO, Keeney GL, Roche PC, Cha SS, Podratz KC. Hetzel DJ, et al. Among authors: cha ss. Gynecol Oncol. 1992 Nov;47(2):179-85. doi: 10.1016/0090-8258(92)90103-p. Gynecol Oncol. 1992. PMID: 1361478

2

Retrospective review of 208 patients with leiomyosarcoma of the uterus: prognostic indicators, surgical management, and adjuvant therapy.

Giuntoli RL 2nd, Metzinger DS, DiMarco CS, Cha SS, Sloan JA, Keeney GL, Gostout BS. Giuntoli RL 2nd, et al. Among authors: cha ss. Gynecol Oncol. 2003 Jun;89(3):460-9. doi: 10.1016/s0090-8258(03)00137-9. Gynecol Oncol. 2003. PMID: 12798712

3

Proliferating cell nuclear antigen in epithelial ovarian cancer: relation to results at second-look laparotomy and survival.

Hartmann LC, Sebo TJ, Kamel NA, Podratz KC, Cha SS, Wieand HS, Keeney GL, Roche PC. Hartmann LC, et al. Among authors: cha ss. Gynecol Oncol. 1992 Nov;47(2):191-5. doi: 10.1016/0090-8258(92)90105-r. Gynecol Oncol. 1992. PMID: 1361479

4

Flow-cytometric DNA analysis of stages IB and IIA cervical carcinoma.

Zanetta GM, Katzmann JA, Keeney GL, Kinney WK, Cha SS, Podratz KC. Zanetta GM, et al. Among authors: cha ss. Gynecol Oncol. 1992 Jul;46(1):13-9. doi: 10.1016/0090-8258(92)90188-o. Gynecol Oncol. 1992. PMID: 1634134

5

Stage I ovarian epithelial carcinoma: survival analysis following definitive treatment.

Lentz SS, Cha SS, Wieand HS, Podratz KC. Lentz SS, et al. Among authors: cha ss. Gynecol Oncol. 1991 Dec;43(3):198-202. doi: 10.1016/0090-8258(91)90019-2. Gynecol Oncol. 1991. PMID: 1752487

6

DNA ploidy in endometrial carcinoma: major objective prognostic factor.

Britton LC, Wilson TO, Gaffey TA, Cha SS, Wieand HS, Podratz KC. Britton LC, et al. Among authors: cha ss. Mayo Clin Proc. 1990 May;65(5):643-50. doi: 10.1016/s0025-6196(12)65126-x. Mayo Clin Proc. 1990. PMID: 2348728

7

Intraoperative radiation therapy in gynecologic cancer: the Mayo Clinic experience.

Garton GR, Gunderson LL, Webb MJ, Wilson TO, Martenson JA Jr, Cha SS, Podratz KC. Garton GR, et al. Among authors: cha ss. Gynecol Oncol. 1993 Mar;48(3):328-32. doi: 10.1006/gyno.1993.1057. Gynecol Oncol. 1993. PMID: 8385058

8

Deoxyribonucleic acid analysis facilitates the pretreatment identification of high-risk endometrial cancer patients.

Podratz KC, Wilson TO, Gaffey TA, Cha SS, Katzmann JA. Podratz KC, et al. Among authors: cha ss. Am J Obstet Gynecol. 1993 Apr;168(4):1206-13; discussion 1213-5. doi: 10.1016/0002-9378(93)90370-x. Am J Obstet Gynecol. 1993. PMID: 8475967

9

DNA index by flow cytometric analysis: an additional prognostic factor in advanced ovarian carcinoma without residual disease after primary operation.

Zanetta G, Keeney GL, Cha SS, Wieand HS, Katzmann JA, Podratz KC. Zanetta G, et al. Among authors: cha ss. Gynecol Oncol. 1996 Aug;62(2):208-12. doi: 10.1006/gyno.1996.0217. Gynecol Oncol. 1996. PMID: 8751551

10

Splenectomy as part of cytoreductive surgery in ovarian cancer.

Magtibay PM, Adams PB, Silverman MB, Cha SS, Podratz KC. Magtibay PM, et al. Among authors: cha ss. Gynecol Oncol. 2006 Aug;102(2):369-74. doi: 10.1016/j.ygyno.2006.03.028. Epub 2006 Apr 24. Gynecol Oncol. 2006. PMID: 16631919 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

402 results

Search Page

Filters